Lixivaptan crystal form V and preparation method and application

The invention relates to a lixivaptan crystal form V and a preparation method thereof, and further relates to a pharmaceutical composition prepared through the lixivaptan crystal form V and an application of the lixivaptan crystal form V. The lixivaptan crystal form V is represented through an X-ray diffraction pattern of powder of the lixivaptan crystal form V.